Thursday, 9 October 2014

DRL, Sun Pharma among 14 cos facing price probe in US

WASHINGTON: India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers that are being probed by the US Congress over price escalation of generic drugs.

In letters sent by Elijah E Cummings (Ranking Member of the House Committee on Oversight and Government Reform), and senator Bernard Sanders, 14 companies have been asked to share "information about the escalating prices they have been charging for generic drugs".

Cummings and Sanders are investigating price increases for drugs used to treat everything from common medical conditions to life-threatening illnesses and to identify measures to help reduce costs for patients, healthcare providers, and hospitals across the country (US), said a statement on the US House of Representatives website.